|
|
| 回到 StockQ 正常版首頁 |
國泰科技生化基金
| ||||||||||
| 2015 | 2016 | 2017 | 2018 | 2019 |
| -7.64% | 10.10% | 25.15% | -21.08% | 47.35% |
| 國泰科技生化基金 |
| 日期 | 淨值 | 漲跌比例 |
| 2020/07/02 | 44.87 | 2.26% |
| 2020/07/01 | 43.88 | 1.67% |
| 2020/06/30 | 43.16 | 1.15% |
| 2020/06/29 | 42.67 | -0.86% |
| 2020/06/24 | 43.04 | 1.01% |
| 2020/06/23 | 42.61 | 0.00% |
| 2020/06/22 | 42.61 | 1.02% |
| 2020/06/19 | 42.18 | -0.09% |
| 2020/06/18 | 42.22 | 2.03% |
| 2020/06/17 | 41.38 | 0.32% |
| 名稱 | 三個月 | 六個月 | 一年 | 今年 | ||
|
34.02% | 3.22% | 34.91% | 4.79% | ||
| NBI生技指數 | 28.61% | 15.60% | 26.18% | 14.89% | ||
| 費城藥物指數 | 0.00% | 0.00% | 0.00% | 0.00% | ||
| AMEX生技指數 | 30.31% | 15.41% | 21.38% | 14.86% | ||
| MSCI 全球醫療保健指數 (price) | 17.14% | 1.74% | 12.54% | 1.91% | ||
| MSCI 製藥指數 (price) | 11.18% | -1.76% | 7.21% | -1.59% | ||
| MSCI 生物科技指數 (price) | 19.83% | 14.71% | 32.25% | 14.76% | ||
|
22.13% | 6.18% | 16.12% | 6.31% | ||
|
21.81% | 5.64% | 14.95% | 5.77% | ||
|
22.16% | 14.12% | 27.75% | 13.29% | ||
|
24.39% | 6.92% | 12.72% | 6.92% | ||
|
17.50% | 3.37% | 16.81% | 3.93% | ||
|
22.06% | 4.30% | 16.54% | 4.44% | ||
|
20.15% | 8.12% | 19.36% | 8.14% | ||
|
19.92% | 6.76% | 9.64% | 6.76% | ||
|
22.78% | 8.59% | 14.81% | 8.59% | ||
|
14.16% | -0.63% | 10.72% | 0.02% | ||
|
32.45% | 14.58% | 23.23% | 13.57% | ||
|
31.98% | 13.81% | 21.58% | 12.81% | ||
|
16.17% | -2.90% | 9.81% | -2.73% | ||
|
24.67% | 5.55% | 15.81% | 5.42% | ||
|
24.36% | 5.03% | 14.67% | 4.86% | ||
|
24.31% | 4.33% | 12.77% | 4.18% | ||
|
24.57% | 4.73% | 13.61% | 4.57% | ||
|
24.90% | 5.94% | 16.70% | 5.80% | ||
|
18.48% | 10.50% | 17.03% | 10.50% | ||
|
28.54% | 14.71% | 21.34% | 14.27% | ||
|
25.50% | 14.95% | 24.76% | 14.99% | ||
|
29.15% | 15.97% | 24.48% | 15.54% | ||
|
20.37% | -0.58% | 5.32% | -0.70% | ||
|
17.52% | -0.34% | 8.34% | -0.04% | ||
|
20.95% | 0.54% | 8.10% | 0.44% | ||
|
35.41% | 17.11% | 29.23% | 17.11% | ||
|
23.23% | 1.05% | 12.33% | 1.05% | ||
|
18.58% | 8.89% | 22.45% | 8.89% | ||
|
21.07% | 5.12% | 19.39% | 5.12% |
|
StockQ 全球指數 手機版 © All rights reserved.
|
